Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Matrix and Savage enter marketing agreement for AccuSite

Aug. 8, 1997

StressGen and Genzyme announce closing of joint venture

Aug. 8, 1997

Genzyme Transgenics' cancer vaccine elicits immune response in myeloma patients

Aug. 7, 1997

HemoCleanse submits 510(k) for ThermoChem-HT

Aug. 7, 1997

New agent for breast cancer in development at Zenyaku Kogyo

Aug. 7, 1997

Antiproliferative agents from Kirin Brewery

Aug. 6, 1997

Korean researchers isolate aminopeptidase inhibitors from microbial source

Aug. 6, 1997

Novel camptothecin analogues reported by Korean scientists

Aug. 6, 1997

KSA-based cancer vaccine in development

Aug. 5, 1997

Seven more marketing approvals announced for Campto

Aug. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...